Table 4.

Audited and coded inter-rater agreement

Condition	This study	Youssef29	Quan41	Kieszak25	Stavem42
Myocardial infarction	0.40	0.34	0.59	0.22	0.66
Congestive heart failure	0.51	0.61	0.80	0.38	0.45
Peripheral vascular disease	0.44	0.42	0.34	0.22	0.47
Cerebrovascular disease	0.32	0.83	0.50	–	0.56
Dementia	0	0.66	0.42	0.26	0.42
Chronic pulmonary disease	0.43	0.78	0.72	0.64	0.65
Hemiplegia/paraplegia	−0.02	0.22	0.55	–	0.31
Rheumatologic disease	/	0.58	0.57	0.20	0.29
Peptic ulcer disease	−0.02	0.62	0.63	0.12	0.31
Diabetes	0.32	0.75	0.74	0.68	0.60
Diabetes with chronic complication	0.64	0.34	0.58	0.16	0.42
Mild liver disease	0.06	0.09	0.53	0	0.42
Moderate liver disease	−0.02	0.43	0.47	–	0.26
Renal disease	0.56	0.75	0.49	0.29	0.60
Any malignancy	0.43	0.77	0.78	0.23	0.49
Metastatic solid tumour	0.71	0.87	0.87	0.20	0.56
AIDS/HIV	/	0.91	0.78	—	–

Inter-rater agreement (kappa values) between audited and coded.